Stockreport

Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose Escalation Clinical Study with Dose Expansion of Oral Triapine® in Combination with Temozolomide ...

TRON GROUP INC  (TGRP) 
US:NYSE Investor Relations: otcmarkets.com/stock/tron/news?id=178154
PDF ALACHUA, Fla. and CHICAGO, May 14, 2024 /PRNewswire/ -- Nanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation [Read more]